WeVote
Log In

Bill

Bill

SB 1716

clozapine; access; monitoring modifications

57th Legislature - Second Regular Session Introduced by Lela Alston and 6 co-sponsors

Arizona bill modifying clozapine access and monitoring requirements for treatment-resistant psychiatric disorders, balancing medication safety oversight with patient treatment access.

Senate First Reading
0
WeVote Research Nonpartisan
Bill Summary · SB 1716

Legislative bill overview

SB 1716 proposes modifications to Arizona's regulations governing clozapine access and monitoring requirements. Clozapine is an antipsychotic medication used primarily for treatment-resistant schizophrenia and severe bipolar disorder, but it carries significant risks requiring careful medical supervision. The bill aims to streamline or alter the current monitoring and access protocols for this medication.

Why is this important

Clozapine is one of the most effective medications for treatment-resistant psychotic disorders, but current federal and state regulations require frequent blood tests and pharmacy monitoring due to the risk of agranulocytosis (dangerous white blood cell depletion). Regulatory barriers can prevent patients who would benefit from clozapine from accessing it. Conversely, any loosening of safety requirements carries medical risks. This bill directly affects people with severe mental illness and the healthcare providers treating them.

Potential points of contention

  • Safety vs. access balance: Relaxing monitoring requirements could improve access for patients but may increase risks of serious adverse effects if side effects aren't caught early
  • Healthcare burden: Streamlined requirements could reduce costs and administrative burden on clinics and patients, but may shift liability or monitoring responsibility to providers unprepared for it
  • Alignment with federal regulations: Arizona must ensure modifications comply with FDA requirements and interstate pharmaceutical standards, which could limit what changes are actually permissible

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.